<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Grace Debeila on Medium]]></title>
        <description><![CDATA[Stories by Grace Debeila on Medium]]></description>
        <link>https://medium.com/@gdebeila?source=rss-120d05b2c739------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*HGSreLjtAfAANKyRcFZdfA.jpeg</url>
            <title>Stories by Grace Debeila on Medium</title>
            <link>https://medium.com/@gdebeila?source=rss-120d05b2c739------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 07:04:30 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@gdebeila/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Austrian Alpine Ascent: The Hills are Alive with the Sound of Alpha!]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/austrian-alpine-ascent-the-hills-are-alive-with-the-sound-of-alpha-bb5f3e65be36?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/600/1*4M8JGdn-zRQshZmV21GzUQ.png" width="600"></a></p><p class="medium-feed-snippet">In the grand orchestra of European equities, Austria rarely takes the conductor&#x2019;s podium. Investors usually chase the bombast of German&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/austrian-alpine-ascent-the-hills-are-alive-with-the-sound-of-alpha-bb5f3e65be36?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/austrian-alpine-ascent-the-hills-are-alive-with-the-sound-of-alpha-bb5f3e65be36?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/bb5f3e65be36</guid>
            <category><![CDATA[derivatives]]></category>
            <category><![CDATA[portfolio-management]]></category>
            <category><![CDATA[macroeconomics]]></category>
            <category><![CDATA[austria]]></category>
            <category><![CDATA[stock-market]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Fri, 04 Jul 2025 23:21:06 GMT</pubDate>
            <atom:updated>2025-07-04T23:21:06.988Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Vital Signs Failing: UnitedHealth’s ICU Moment and a Grinold-Kroner Diagnosis]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/vital-signs-failing-unitedhealths-icu-moment-and-a-grinold-kroner-diagnosis-e12e8e2d1b4c?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/600/1*JxFwX_y2WYgDCO24GTcATQ.png" width="600"></a></p><p class="medium-feed-snippet">UnitedHealth Group (NYSE: UNH), once the picture of robust health, has suffered a massive cardiac arrest. Down more than 40% year-to-date&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/vital-signs-failing-unitedhealths-icu-moment-and-a-grinold-kroner-diagnosis-e12e8e2d1b4c?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/vital-signs-failing-unitedhealths-icu-moment-and-a-grinold-kroner-diagnosis-e12e8e2d1b4c?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/e12e8e2d1b4c</guid>
            <category><![CDATA[unitedhealth-group]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[investing]]></category>
            <category><![CDATA[stock-market]]></category>
            <category><![CDATA[equity]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Fri, 30 May 2025 16:35:49 GMT</pubDate>
            <atom:updated>2025-05-30T16:35:49.504Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Semiconductor Stunner: Scrutinising NVIDIA’s Stratospheric Returns with Grinold-Kroner Model]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/semiconductor-stunner-scrutinising-nvidias-stratospheric-returns-with-grinold-kroner-model-3906ead6f33a?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/960/1*CJgEA6BBY-JqJmzovy5ydQ.png" width="960"></a></p><p class="medium-feed-snippet">Houston, we have a puzzle!</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/semiconductor-stunner-scrutinising-nvidias-stratospheric-returns-with-grinold-kroner-model-3906ead6f33a?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/semiconductor-stunner-scrutinising-nvidias-stratospheric-returns-with-grinold-kroner-model-3906ead6f33a?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/3906ead6f33a</guid>
            <category><![CDATA[fundamental-analysis]]></category>
            <category><![CDATA[semiconductors]]></category>
            <category><![CDATA[nvidia]]></category>
            <category><![CDATA[grinold-kroner-model]]></category>
            <category><![CDATA[earnings]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Thu, 27 Mar 2025 17:20:24 GMT</pubDate>
            <atom:updated>2025-03-29T19:16:23.626Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Web of Value: Weaving P/E-rfect Portfolios with Network Theory]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/web-of-value-weaving-p-e-rfect-portfolios-with-network-theory-5d5c82825c53?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/600/1*QpKcN1dG9jgfVLhLMoFfjg.png" width="600"></a></p><p class="medium-feed-snippet">In today&#x2019;s tech market, where giants like NVIDIA command breathtaking valuations, investors face a critical challenge: How do you separate&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/web-of-value-weaving-p-e-rfect-portfolios-with-network-theory-5d5c82825c53?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/web-of-value-weaving-p-e-rfect-portfolios-with-network-theory-5d5c82825c53?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/5d5c82825c53</guid>
            <category><![CDATA[data-science]]></category>
            <category><![CDATA[python]]></category>
            <category><![CDATA[network-theory]]></category>
            <category><![CDATA[portfolio-optimization]]></category>
            <category><![CDATA[quantitative-finance]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Sat, 22 Feb 2025 19:02:50 GMT</pubDate>
            <atom:updated>2025-02-22T20:46:20.414Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Beyond the Benchmark: Meandering through 2024’s Equity Market Maze]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/beyond-the-benchmark-meandering-through-2024s-equity-market-maze-87bf949e17a1?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/960/1*uCgOo-xYze3fLEExTOuw2Q.png" width="960"></a></p><p class="medium-feed-snippet">The global equity markets of 2024 presented themselves as an intricate maze, where traditional investment paths twisted into unexpected&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/beyond-the-benchmark-meandering-through-2024s-equity-market-maze-87bf949e17a1?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/beyond-the-benchmark-meandering-through-2024s-equity-market-maze-87bf949e17a1?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/87bf949e17a1</guid>
            <category><![CDATA[portfolio-management]]></category>
            <category><![CDATA[equity]]></category>
            <category><![CDATA[etf]]></category>
            <category><![CDATA[stock-market]]></category>
            <category><![CDATA[investing]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Sat, 11 Jan 2025 15:41:31 GMT</pubDate>
            <atom:updated>2025-01-11T15:41:31.239Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Sip, Swirl & Strategize: A Yield Curve Sommelier’s Guide to the Art of Fixed Income Portfolio…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/sip-swirl-strategize-a-yield-curve-sommeliers-guide-to-the-art-of-fixed-income-portfolio-1469f6a75491?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/600/1*fYn1WcujviX9CAykrOatkw.png" width="600"></a></p><p class="medium-feed-snippet">QUANDOYEN &#x2014; Bespoke Quantitative Expertise</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/sip-swirl-strategize-a-yield-curve-sommeliers-guide-to-the-art-of-fixed-income-portfolio-1469f6a75491?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/sip-swirl-strategize-a-yield-curve-sommeliers-guide-to-the-art-of-fixed-income-portfolio-1469f6a75491?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/1469f6a75491</guid>
            <category><![CDATA[yield-curve]]></category>
            <category><![CDATA[fixed-income]]></category>
            <category><![CDATA[derivatives]]></category>
            <category><![CDATA[portfolio-management]]></category>
            <category><![CDATA[investment-management]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Mon, 23 Dec 2024 12:20:13 GMT</pubDate>
            <atom:updated>2024-12-23T22:05:21.924Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Novo Nordisk’s Trials and Tribulations: A Merton Model Prescription for Understanding the Risks…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-42f8ac39c3d6?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/960/1*Yl-ekH2IShBOrXobnzHtDQ.png" width="960"></a></p><p class="medium-feed-snippet">Having dissected Novo Nordisk&#x2019;s liabilities in Part 2, we&#x2019;re now ready to examine another vital sign in our Merton model checkup&#x200A;&#x2014;&#x200A;the&#x2026;</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-42f8ac39c3d6?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-42f8ac39c3d6?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/42f8ac39c3d6</guid>
            <category><![CDATA[investment-management]]></category>
            <category><![CDATA[yield-curve]]></category>
            <category><![CDATA[debt]]></category>
            <category><![CDATA[novo-nordisk]]></category>
            <category><![CDATA[credit-risk]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Fri, 22 Nov 2024 13:32:55 GMT</pubDate>
            <atom:updated>2025-01-05T20:14:21.646Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Novo Nordisk’s Trials and Tribulations: A Merton Model Approach for Diagnosing the Risks (Part 2 of…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-0f8bccbb6706?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/600/1*KtQDvlFjSGXt0QvKCOd6cA.png" width="600"></a></p><p class="medium-feed-snippet">As we dig deeper into Novo Nordisk&#x2019;s financial health using the Merton model, it&#x2019;s time to shine a light on the company&#x2019;s debt schedule.</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-0f8bccbb6706?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-0f8bccbb6706?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/0f8bccbb6706</guid>
            <category><![CDATA[financial-analysis]]></category>
            <category><![CDATA[debt]]></category>
            <category><![CDATA[credit-risk]]></category>
            <category><![CDATA[novo-nordisk]]></category>
            <category><![CDATA[options]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Thu, 14 Nov 2024 22:22:24 GMT</pubDate>
            <atom:updated>2025-01-05T19:14:41.827Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Novo Nordisk’s Trials and Tribulations: A Merton Model Approach for Diagnosing the Risks (Part 1 of…]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-b5d9cc39972c?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/960/1*kXoQsEs4knHg0lwwnZdKIA.png" width="960"></a></p><p class="medium-feed-snippet">It seems the Nordic giant Novo Nordisk has caught a nasty case of the blues.</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-b5d9cc39972c?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/novo-nordisks-trials-and-tribulations-a-merton-model-prescription-for-understanding-the-risks-b5d9cc39972c?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/b5d9cc39972c</guid>
            <category><![CDATA[credit-risk]]></category>
            <category><![CDATA[investment]]></category>
            <category><![CDATA[equity]]></category>
            <category><![CDATA[novo-nordisk]]></category>
            <category><![CDATA[derivatives]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Tue, 12 Nov 2024 12:06:45 GMT</pubDate>
            <atom:updated>2025-01-05T12:22:47.091Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[The Viking Portfolio: Unpacking Denmark’s Equity Market Dominance]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://medium.com/@gdebeila/the-viking-portfolio-unpacking-denmarks-equity-market-dominance-5d7ca43ffd18?source=rss-120d05b2c739------2"><img src="https://cdn-images-1.medium.com/max/960/1*SCAh0WvuKLzN4OWRlE0LnQ.png" width="960"></a></p><p class="medium-feed-snippet">QUANDOYEN: BESPOKE QUANTITATIVE EXPERTISE</p><p class="medium-feed-link"><a href="https://medium.com/@gdebeila/the-viking-portfolio-unpacking-denmarks-equity-market-dominance-5d7ca43ffd18?source=rss-120d05b2c739------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://medium.com/@gdebeila/the-viking-portfolio-unpacking-denmarks-equity-market-dominance-5d7ca43ffd18?source=rss-120d05b2c739------2</link>
            <guid isPermaLink="false">https://medium.com/p/5d7ca43ffd18</guid>
            <category><![CDATA[dividends]]></category>
            <category><![CDATA[stock-market]]></category>
            <category><![CDATA[liquidity]]></category>
            <category><![CDATA[denmark]]></category>
            <category><![CDATA[performance]]></category>
            <dc:creator><![CDATA[Grace Debeila]]></dc:creator>
            <pubDate>Tue, 29 Oct 2024 20:01:32 GMT</pubDate>
            <atom:updated>2025-01-05T21:07:02.772Z</atom:updated>
        </item>
    </channel>
</rss>